EssilorLuxottica [EL] vs Amplitude Surgical [AMPLI] Detailed Stock Comparison

EssilorLuxottica
Euronext
Loading...

Amplitude Surgical
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: EssilorLuxottica wins in 12 metrics, Amplitude Surgical wins in 5 metrics, with 0 ties. EssilorLuxottica appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | EssilorLuxottica | Amplitude Surgical | Better |
---|---|---|---|
P/E Ratio (TTM) | 48.88 | 310.00 | EssilorLuxottica |
Price-to-Book Ratio | 3.07 | 3.14 | EssilorLuxottica |
Debt-to-Equity Ratio | 36.58 | 126.32 | EssilorLuxottica |
PEG Ratio | 32.88 | N/A | N/A |
EV/EBITDA | 22.54 | 15.95 | Amplitude Surgical |
Profit Margin (TTM) | 8.74% | 1.00% | EssilorLuxottica |
Operating Margin (TTM) | 14.25% | 11.52% | EssilorLuxottica |
EBITDA Margin (TTM) | 14.25% | 11.52% | EssilorLuxottica |
Return on Equity | 6.44% | 1.15% | EssilorLuxottica |
Return on Assets (TTM) | 3.58% | 3.10% | EssilorLuxottica |
Free Cash Flow (TTM) | $3.35B | $-14.89M | EssilorLuxottica |
Dividend Yield | 1.64% | N/A | N/A |
1-Year Return | 21.29% | 100.00% | Amplitude Surgical |
Price-to-Sales Ratio (TTM) | 4.33 | 2.76 | Amplitude Surgical |
Enterprise Value | $126.81B | $397.58M | EssilorLuxottica |
EV/Revenue Ratio | 4.66 | 3.67 | Amplitude Surgical |
Revenue per Share (TTM) | $60 | $2 | EssilorLuxottica |
Earnings per Share (Diluted) | $5.16 | $0.02 | EssilorLuxottica |
Beta (Stock Volatility) | 0.74 | 0.13 | Amplitude Surgical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
EssilorLuxottica vs Amplitude Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
EssilorLuxottica | 0.28% | -0.94% | 5.64% | 3.61% | -7.12% | 7.98% |
Amplitude Surgical | 0.00% | 0.00% | 0.81% | 1.64% | 81.29% | 93.75% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
EssilorLuxottica | 21.29% | 55.25% | 130.01% | 121.45% | 267.48% | 267.48% |
Amplitude Surgical | 100.00% | 100.65% | 192.45% | 12.52% | 26.53% | 26.53% |
Performance & Financial Health Analysis: EssilorLuxottica vs Amplitude Surgical
Metric | EL | AMPLI |
---|---|---|
Market Information | ||
Market Cap | €117.98B | €299.85M |
Market Cap Category | Large cap | Mid cap |
10 Day Avg. Volume | 484,501 | 638 |
90 Day Avg. Volume | 429,838 | 5,752 |
Last Close | €252.90 | €6.20 |
52 Week Range | €202.10 - €298.00 | €2.96 - €6.25 |
% from 52W High | -15.13% | -0.80% |
All-Time High | €298.00 (Feb 10, 2025) | €6.25 (May 30, 2025) |
% from All-Time High | -15.13% | -0.80% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.06% | 0.05% |
Quarterly Earnings Growth | 0.02% | N/A |
Financial Health | ||
Profit Margin (TTM) | 0.09% | 0.01% |
Operating Margin (TTM) | 0.14% | 0.12% |
Return on Equity (TTM) | 0.06% | 0.01% |
Debt to Equity (MRQ) | 36.58 | 126.32 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | €82.02 | €1.97 |
Cash per Share (MRQ) | €6.04 | €0.41 |
Operating Cash Flow (TTM) | €4.91B | €5.93M |
Levered Free Cash Flow (TTM) | €3.07B | €-11,550,125 |
Dividends | ||
Last 12-Month Dividend Yield | 1.64% | N/A |
Last 12-Month Dividend | €3.95 | N/A |
Valuation & Enterprise Metrics Analysis: EssilorLuxottica vs Amplitude Surgical
Metric | EL | AMPLI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 48.88 | 310.00 |
Forward P/E | 32.88 | N/A |
PEG Ratio | 32.88 | N/A |
Price to Sales (TTM) | 4.33 | 2.76 |
Price to Book (MRQ) | 3.07 | 3.14 |
Market Capitalization | ||
Market Capitalization | €117.98B | €299.85M |
Enterprise Value | €126.81B | €397.58M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.66 | 3.67 |
Enterprise to EBITDA | 22.54 | 15.95 |
Risk & Other Metrics | ||
Beta | 0.74 | 0.13 |
Book Value per Share (MRQ) | €82.02 | €1.97 |
Financial Statements Comparison: EssilorLuxottica vs Amplitude Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | EL | AMPLI |
---|---|---|
Revenue/Sales | N/A | N/A |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | N/A | N/A |
Income Tax | N/A | N/A |
Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | EL | AMPLI |
---|---|---|
Cash & Equivalents | €2.25B | €29.10M |
Total Current Assets | €10.04B | €94.65M |
Total Current Liabilities | €10.56B | €46.91M |
Long-Term Debt | €9.80B | €102.01M |
Total Shareholders Equity | €41.00B | €95.82M |
Retained Earnings | €2.36B | €1.53M |
Property, Plant & Equipment | €9.17B | €50.75M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | EL | AMPLI |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | EL | AMPLI |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 484,501 | 638 |
Average Daily Volume (90 Day) | 429,838 | 5,752 |
Shares Outstanding | 456.71M | 47.99M |
Float Shares | 293.63M | 47.90M |
% Held by Insiders | 0.37% | 0.01% |
% Held by Institutions | 0.30% | 0.75% |
Dividend Analysis & Yield Comparison: EssilorLuxottica vs Amplitude Surgical
Metric | EL | AMPLI |
---|---|---|
Last 12-Month Dividend | €3.95 | N/A |
Last 12-Month Dividend Yield | 1.64% | N/A |
3-Year Avg Annual Dividend | €3.71 | N/A |
3-Year Avg Dividend Yield | 1.79% | N/A |
3-Year Total Dividends | €11.13 | N/A |
Ex-Dividend Date | May 07, 2025 | N/A |